Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000020581 | SCV000541896 | uncertain significance | Neuroblastoma, susceptibility to, 3 | 2024-01-18 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 1087 of the ALK protein (p.Thr1087Ile). This variant is present in population databases (rs113994090, gnomAD 0.03%). This missense change has been observed in individual(s) with neuroblastoma (PMID: 18923524). ClinVar contains an entry for this variant (Variation ID: 21395). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change does not substantially affect ALK function (PMID: 23104988). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV000997104 | SCV001152219 | uncertain significance | not provided | 2018-04-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000997104 | SCV002584474 | uncertain significance | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in a patient with neuroblastoma and in individuals with breast cancer in published literature (Chen et al., 2008; Shin et al., 2020); Published functional studies demonstrate neurite growth stimulation, cellular proliferation, and foci development similar to wild type (Chand et al., 2013); This variant is associated with the following publications: (PMID: 23201355, 21945349, 32019277, 18923524, 23104988, Qiu2022[article]) |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153305 | SCV003843554 | benign | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000020581 | SCV004198522 | uncertain significance | Neuroblastoma, susceptibility to, 3 | 2023-10-02 | criteria provided, single submitter | clinical testing |